cP12
Phase 2Recruiting 0 watching 0 views this week⚡ Active
49
Development Stage
✓
Pre-clinical✓
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Thermal Burns
Conditions
Thermal Burns
Trial Timeline
May 12, 2025 → Nov 1, 2026
NCT ID
NCT06814717About cP12
cP12 is a phase 2 stage product being developed by United Therapeutics for Thermal Burns. The current trial status is recruiting. This product is registered under clinical trial identifier NCT06814717. Target conditions include Thermal Burns.
Hype Score Breakdown
Clinical
17
Activity
12
Company
7
Novelty
5
Community
5
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT06814717 | Phase 2 | Recruiting |
Competing Products
4 competing products in Thermal Burns
| Product | Company | Stage | Hype Score |
|---|---|---|---|
| R475 + Placebo | Sanofi | Phase 2 | 51 |
| NexoBrid | MediWound | Pre-clinical | 15 |
| NexoBrid + Gel Vehicle | MediWound | Phase 3 | 69 |
| NexoBrid | MediWound | Phase 3 | 69 |